On the UZ Gent campus, a new GMP unit is being built, covering no less than 1000 m2 and meeting the latest quality requirements. The new GMP unit will be fully operational by the end of 2026.

With the new facilities, the University Hospital of Ghent (UZ Gent) continues to facilitate research into innovative applications of cell and gene therapy, to make it more accessible to patients and to establish partnerships with innovative third parties.

The location on the campus of Ghent University Hospital ensures synergies with both the hospital and Ghent University. It also benefits from Ghent’s reputation as a leading cluster for biotech and medical companies, and its position as a gateway to Europe and the world.

Bart Vandekerckhove: “At UZ Gent, we have about eight years of practical experience with advanced medicine and gathered a lot of know how in the meantime. For lung cancer patients, among others, we recently made a number of promising innovative therapies. We are currently working with 15 employees in our existing GMP unit. If the construction proceeds as planned, we will move to the new, a 1000 m2 full floor unit, by the end 2026. That area also includes a warehouse, quality lab and meeting room.”

Prof Bart Vandekerckhove, Dir CellGENTherapies

Sponsors